News Focus
News Focus
icon url

Dr Bala

09/10/22 12:25 PM

#512676 RE: HyGro #512667

Thanks, HyGro. The DCVax-L therapy will be approved by all the RAs.
icon url

hoffmann6383

09/10/22 1:20 PM

#512699 RE: HyGro #512667

Agree. People try to mislead investors all the time with repeated nonsense.
icon url

sukus

09/10/22 1:23 PM

#512700 RE: HyGro #512667

Exactly HyGro. The data will speak louder. Thanks for pointing it out without fear.
icon url

biosectinvestor

09/10/22 2:09 PM

#512718 RE: HyGro #512667

The regulators approved the trial and the updated SAP, pre-unblinding. MHRA is allowing the drug to be manufactured and sold at full price in the UK pre-approval on a compassionate basis. Unheard of…

The professionals are the experts, not anonymous posters on bulletin boards who post false information non-stop on social media and who admittedly invest in competing technologies with flawed technology and trials themselves.

I will look at the facts, and expert presentations, not the ramblings of obsessed posters online who can’t get their facts straight.
icon url

Roman516

09/10/22 3:29 PM

#512735 RE: HyGro #512667

Manufacturing, manufacturing, and more manufacturing

Per your comment
"Professionals given incomplete data without the relevant background can be mislead like shareholders. How many professionals that don't have conflict of interest, have had the full story of the manipulated protocol/SAP, the confounding of the naïve OS, the post hoc data dredging of the recurrent GBM data."

As a professional, scientist, researcher, business executive, with well over 45+ years of product design and development, I am grateful to have successfully created multiple products to market that are now worth well over billions of dollars. My experience and relative background have spanned every aspect of the entire product design and development process. I would have not invested in NWBO if I knew that the data was skewed, manipulated, and other misleading fabrications by confounded outsiders trying to spin bogus information.
The bottom line, many doctors, scientist, professionals and present their case to support NWBO and the fact of the matter is that they are extremely impressed with the OS results not the superficial PFS statistical estimations, but the real results as already present as well as posted. Furthermore, I will not address the FDA at this point but understand the process for approval by the FDA and other agencies that require manufacturing stability, volume production capability and knowing that NWBO has a solid team in place to back up their claims. Not to mention the fact that there is a vast array of external manufacturing partnerships that are involved and support NWBO. Including, multiple university support, a host of doctors, scientist, and professionals that are all worthy. NWBO is moving forward and that is all that matters, IMPO.